Doximity (DOCS) Stock Price, News & Analysis

Company Overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Key Stats

• Today's Range: $55.13 to $58.88
• 50-Day Range: $55.38 to $83.11
• 52-Week Range: $22.96 to $85.21
• Volume: 1.82 million shs
• Average Volume: 1.94 million shs
• Market Capitalization: $10.82 billion
• P/E Ratio: 57.96
• Dividend Yield: N/A
• Price Target: $64.22
• Consensus Rating: Moderate Buy

Doximity Stock Analysis - MarketRank™

Doximity scored higher than 66% of companies evaluated by MarketBeat, and ranked 355th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Doximity has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 8 buy ratings, 11 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Doximity has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.08%

Earnings Growth

Earnings for Doximity are expected to grow by 8.08% in the coming year, from $0.99 to $1.07 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Doximity is 57.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.58.

Price to Earnings Ratio vs. Sector

The P/E ratio of Doximity is 57.96, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.62.

Price to Earnings Growth Ratio

Doximity has a PEG Ratio of 4.10. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Doximity has a P/B Ratio of 10.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DOCS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Doximity does not currently pay a dividend.

Dividend Growth

Doximity does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for DOCS.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.26

News Sentiment

Doximity has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Doximity this week, compared to 10 articles on an average week.

Search Interest

Only 23 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -32% compared to the previous 30 days.

MarketBeat Follows

17 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 6% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,152,400.00 in company stock.

Percentage Held by Insiders

37.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DOCS Stock Analysis - Frequently Asked Questions

How have DOCS shares performed this year?

Doximity's stock was trading at $53.39 on January 1st, 2025. Since then, DOCS stock has increased by 8.6% and is now trading at $57.96.
View the best growth stocks for 2025 here.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) released its quarterly earnings data on Thursday, November, 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by $0.02. The company earned $136.83 million during the quarter, compared to analysts' expectations of $127.05 million. Doximity had a net margin of 36.60% and a trailing twelve-month return on equity of 21.75%.

When did Doximity IPO?

Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Doximity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 4/02/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Custom computer programming services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:DOCS
• CIK: 1516513
• Web: www.doximity.com
• Phone: 650-549-4330
• Fax: N/A
• Employees: 890
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $64.22
• High Stock Price Target: $90.00
• Low Stock Price Target: $45.00
• Potential Upside/Downside: +10.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 21 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.00
• Trailing P/E Ratio: 57.96
• Forward P/E Ratio: 58.55
• P/E Growth: 4.1
• Net Income: $147.58 million
• Net Margins: 36.60%
• Pretax Margin: 46.01%
• Return on Equity: 21.75%
• Return on Assets: 18.64%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.74
• Quick Ratio: 8.74

Sales & Book Value

• Annual Sales: $550.17 million
• Price / Sales: 19.67
• Cash Flow: $0.71 per share
• Price / Cash Flow: 81.32
• Book Value: $5.52 per share
• Price / Book: 10.50

Miscellaneous

• Outstanding Shares: 186,692,000
• Free Float: 116,869,000
• Market Cap: $10.82 billion
• Optionable: Not Optionable
• Beta: 1.34